Arrigo Francesco Giuseppe Cicero: Redefining the Role of Urate-Lowering Therapy in Cardiovascular Disease
Arrigo Francesco Giuseppe Cicero, Head and Associate Professor of Human Nutrition at Alma Mater Studiorum – University of Bologna and President at SiNut Official, shared a post on LinkedIn about a recent article he and his colleges co-authored published in European Heart Journal – Cardiovascular Pharmacotherapy, adding:
“I am pleased to share our latest review, published in European Heart Journal – Cardiovascular Pharmacotherapy:
‘Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio–renal–metabolic risk modulation’
In this article, we discuss the role of serum uric acid and urate-lowering therapy within the broader cardio–renal–metabolic risk continuum, integrating epidemiological evidence, Mendelian randomization data, pharmacological considerations, and clinical trial findings.
Many thanks to Claudio Borghi and to Federica Fogacci for her outstanding ability to critically re-discuss an established argument.”
Title: Urate-lowering therapy in cardiovascular pharmacotherapy: from Mendelian randomization data to cardio–renal–metabolic risk modulation
Authors: Claudio Borghi, Federica Fogacci, Arrigo F G Cicero
Stay updated on all scientific advances with Hemostasis Today.
-
Oct 6, 2026, 10:15Zeeshan Ali Baig: AI-Designed Peptide for Rare Bleeding Disorder
-
Oct 6, 2026, 10:12Srivatsan Rangachari: Stem Cell Transplant for 12-Year-Old with Fanconi Anaemia
-
Oct 6, 2026, 09:56Anitha Narayanamurthy: A Possible Missing Link in Unexplained Blood Test Abnormalities
-
Oct 6, 2026, 09:46Francois Roubille: Biomarkers and Long-Term Prognosis After Revascularised STEMI
-
Oct 6, 2026, 09:20EAS Rare Lipid Disorder Course – Advancing Lipid Disorder Education – European Atherosclerosis Society
-
Oct 6, 2026, 09:12Fionnuala Ní Áinle: Lisa Ryan’s First Thrombocalc VTE Research Report
-
Oct 6, 2026, 09:02David McIntosh: Preventable Maternal and Newborn Deaths – The Urgent Need for Action
-
Oct 6, 2026, 08:55Konstantin Yenkoyan: CAR-T, GLP-1 or Orexin – Who Will Take the 2026 Nobel?
-
Oct 6, 2026, 08:39Emily Bury: Putting Patients at the Centre of VTE Care